Eating Disorder Not Otherwise Specified Clinical Trials
2 recruiting trials for Eating Disorder Not Otherwise Specified. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Eating Disorder Not Otherwise Specified clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Forschungsinstitut der Diabetes Akademie Mergentheim (1), Virginia Commonwealth University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Screening Questionnaire (behavioral, 1 trial), followed by Pre-Intervention Questionnaires (~10 minutes), SSI (Single-session intervention (~30 minutes) Active arm.
Track Eating Disorder Not Otherwise Specified trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
Mental conditions and disorders (e.g. distress, depressive, anxiety, and eating disorders) are more prevalent in people with diabetes (PWD) and associated with reduced quality of...
A Single-session Intervention Adaptation of the Habit Framework for the Prevention of Eating Disorders
The purpose of this proposal is to launch the first trial of a single-session intervention (SSI) specifically for the prevention of eating disorders (EDs).
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Eating Disorder Not Otherwise Specified, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Eating Disorder Not Otherwise Specified, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Eating Disorder Not Otherwise Specified, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.